GTR 114055829
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2025-25 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml)
ICB — International Competitive Bid
Closes Nov 30, 2026
Western Europe
Tender Information
GTR Reference
114055829
Tendering Authority
Subscribe to view
Tender No
386710-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Open House Biologics Discount Agreements 2025-25 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
30-11-2026
Work Detail
Pharmaceutical Products – Open House Biologics Discount Agreements 2025-25 - Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml). The Aim Is To Conclude Drug Discount Contracts In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Aflibercept (Atc: S01la05; Potency: 40 Mg/Ml) As Part Of An Open-House Procedure.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
a40c64f9-0c51-4396-82f2-6f12b1155f40.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.